Date of birth: 26.11.1972
- 2015-: CEO Navamedic ASA
Tom Rönnlund has nearly 20 years’ experience working in sales, marketing and management positions in the life science industry. Prior to joining Navamedic Tom was IMS Health's General Manager for the Nordic and Baltic region. Previous experience includes being Country Manager in Sweden for Bristol-Myers Squibb, Business Unit Director at Eli Lilly Sweden and Denmark. Tom Rönnlund holds a Masters degree in Business Administration and Economics from Stockholm University. Mr. Rönnlund holds 40 000 shares in the Company.
Toril Marie Ås
Toril Marie Ås has more than 20 years’ experience of leading finance functions in ICT, media and services industry organizations. Prior to joining Navamedic she has held the position as CFO for Telenor Media Invest, been Finance Director for the Telenor division ‘Corporate Functions and Group Activities’ and been serving at several boards like Amedia, RiksTV, Norges Television, Tv2 Zebra, HMS Norge. Toril holds a MSc in Business from Bodø Graduate School of Business and a MSc in Management from London Business School.
Position: Chief Scientific Officer
Date of birth: 07.06.1974
2010-: CSO Navamedic ASA
aster of Science in Biology from Norwegian University of Science and Technology, Trondheim
Position: CEO Observe Medical Int.
Date of birth: 1966
MBA from Kellogg School of Management, Chicago USA.
Magnus Emmoth is one of OM’s three founders. Magnus Emmoth has extensive experience from a career that, as well as spanning the finance sector, also includes leading positions at a number of medtech companies. His experience ranges from early-stage business development to management positions within larger business concerns. Magnus was among other also responsible for the urological division in the Nordics at Covidien.